Cell Surface-expressed Phosphatidylserine and Annexin A5 Open a Novel Portal of Cell Entry*

Expression of phosphatidylserine (PtdSer) at the cell surface is part of the membrane dynamics of apoptosis. Expressed phosphatidylserine functions as an “eat me” flag toward phagocytes. Here, we report that the expressed phosphatidylserine forms part of a hitherto undescribed pinocytic pathway. Annexin A5, a phosphatidylserine-binding protein, binds to and polymerizes through protein-protein interactions on membrane patches expressing phosphatidylserine. The two-dimensional protein network of annexin A5 at the surface prevents apoptotic body formation without interfering with the progression of apoptosis as demonstrated by activation of caspase-3, PtdSer exposure, and DNA fragmentation. The annexin A5 protein network bends the membrane patch nanomechanically into the cell and elicits budding, endocytic vesicle formation, and cytoskeleton-dependent trafficking of the endocytic vesicle. Annexin A1, which binds to PtdSer without forming a two-dimensional protein network, does not induce the formation of endocytic vesicles. This novel pinocytic pathway differs from macropinocytosis, which is preceded by membrane ruffling and actin polymerization. We clearly showed that actin polymerization is not involved in budding and endocytic vesicle formation but is required for intracellular trafficking. The phosphatidylserine-annexin A5-mediated pinocytic pathway is not restricted to cells in apoptosis. We demonstrated that living tumor cells can take up substances through this novel portal of cell entry. This opens new avenues for targeted drug delivery and cell entry.

[1]  F. Baas,et al.  Neutrophils in Barth syndrome (BTHS) avidly bind annexin-V in the absence of apoptosis. , 2004, Blood.

[2]  C. Reutelingsperger,et al.  The ApoCorrect assay: a novel, rapid method to determine the biological functionality of radiolabeled and fluorescent Annexin A5. , 2004, Analytical biochemistry.

[3]  C. D. De Zeeuw,et al.  Cell surface exposure of phosphatidylserine during apoptosis is phylogenetically conserved , 2004, Apoptosis.

[4]  Sandra L. Schmid,et al.  Regulated portals of entry into the cell , 2003, Nature.

[5]  S. Ran,et al.  Phosphatidylserine is a marker of tumor vasculature and a potential target for cancer imaging and therapy. , 2002, International journal of radiation oncology, biology, physics.

[6]  Richard G. W. Anderson,et al.  Dual control of caveolar membrane traffic by microtubules and the actin cytoskeleton , 2002, Journal of Cell Science.

[7]  Ian G. Mills,et al.  Curvature of clathrin-coated pits driven by epsin , 2002, Nature.

[8]  S. Moss,et al.  Annexins: from structure to function. , 2002, Physiological reviews.

[9]  P. Doevendans,et al.  Real-time imaging of apoptotic cell-membrane changes at the single-cell level in the beating murine heart , 2001, Nature Medicine.

[10]  F. Blankenberg,et al.  Annexin-V imaging for noninvasive detection of cardiac allograft rejection , 2001, Nature Medicine.

[11]  A. Ridley,et al.  Phosphatidylserine (PS) induces PS receptor–mediated macropinocytosis and promotes clearance of apoptotic cells , 2001, The Journal of cell biology.

[12]  C. Reutelingsperger,et al.  Transient expression of phosphatidylserine at cell-cell contact areas is required for myotube formation. , 2001, Journal of cell science.

[13]  Marcel Leist,et al.  Four deaths and a funeral: from caspases to alternative mechanisms , 2001, Nature Reviews Molecular Cell Biology.

[14]  B. de Kruijff,et al.  Visualizing detergent resistant domains in model membranes with atomic force microscopy , 2001, FEBS letters.

[15]  E. Sahai,et al.  Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I , 2001, Nature Cell Biology.

[16]  N. Govorukhina,et al.  Structure of membrane-bound annexin A5 trimers: a hybrid cryo-EM - X-ray crystallography study. , 2000, Journal of molecular biology.

[17]  John Savill,et al.  Corpse clearance defines the meaning of cell death , 2000, Nature.

[18]  M. Hengartner The biochemistry of apoptosis , 2000, Nature.

[19]  P. Doevendans,et al.  Visualisation of cell death in vivo in patients with acute myocardial infarction , 2000, The Lancet.

[20]  H. Hydén,et al.  A receptor for phosphatidylserine-speci ® c clearance of apoptotic cells , 2000 .

[21]  R. Scheuermann,et al.  Annexin V staining due to loss of membrane asymmetry can be reversible and precede commitment to apoptotic death. , 1999, Experimental cell research.

[22]  J. Laplanche,et al.  Annexin V delays apoptosis while exerting an external constraint preventing the release of CD4+ and PrPc+ membrane particles in a human T lymphocyte model. , 1999, Journal of immunology.

[23]  R. Davis,et al.  Imaging of apoptosis (programmed cell death) with 99mTc annexin V. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[24]  Brisson,et al.  Growth of Protein 2-D Crystals on Supported Planar Lipid Bilayers Imaged in Situ by AFM. , 1998, Journal of structural biology.

[25]  C. D. De Zeeuw,et al.  In situ detection of apoptosis during embryogenesis with annexin V: from whole mount to ultrastructure. , 1997, Cytometry.

[26]  C. I. Zeeuw,et al.  Phosphatidylserine plasma membrane asymmetry in vivo: a pancellular phenomenon which alters during apoptosis , 1997, Cell Death and Differentiation.

[27]  J. Oudinet,et al.  Inhibition of Cytosolic Phospholipase A2 by Annexin V in Differentiated Permeabilized HL-60 Cells , 1997, The Journal of Biological Chemistry.

[28]  C. Reutelingsperger,et al.  A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture. , 1996, Cytometry.

[29]  D. Green,et al.  Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl , 1995, The Journal of experimental medicine.

[30]  J. Freyssinet,et al.  Sub-domain structure of lipid-bound annexin-V resolved by electron image analysis. , 1991, Journal of molecular biology.

[31]  R. Huber,et al.  The crystal and molecular structure of human annexin V, an anticoagulant protein that binds to calcium and membranes. , 1990, The EMBO journal.

[32]  R. Huber,et al.  The calcium binding sites in human annexin V by crystal structure analysis at 2.0 A resolution Implications for membrane binding and calcium channel activity , 1990, FEBS letters.

[33]  H C Hemker,et al.  Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers. , 1990, The Journal of biological chemistry.

[34]  K. Fujikawa,et al.  Phospholipid binding properties of human placental anticoagulant protein-I, a member of the lipocortin family. , 1989, The Journal of biological chemistry.